<?xml version="1.0" encoding="UTF-8"?>
<p id="p0200">There was the in-vitro evidence of inhibitory action on the viral replication of viperin among a broad spectrum of DNA and RNA viruses, including herpes viruses, West Nile virus, dengue virus, sindbis virus, influenza A virus, dendai virus, and HIV-1 [
 <xref rid="bb0725" ref-type="bibr">145</xref>]. A traditional Chinese medicinal herb, emodin, is an anthraquinone compound that exhibits the interaction of the SARS-CoV-II spike proteins and ACE2 in the cell line studies [
 <xref rid="bb0730" ref-type="bibr">146</xref>,
 <xref rid="bb0735" ref-type="bibr">147</xref>]. The antipsychotic drug, promazine, has a similar structure to emodin on its spike protein binding site structure that contributes to the replication suppression of SARS-CoV. Promazine displayed the more potent spike-protein-mediated ACE2 binding inhibition than emodin [
 <xref rid="bb0150" ref-type="bibr">30</xref>,
 <xref rid="bb0740" ref-type="bibr">148</xref>]. Despite all these in-vitro evidence, there is still no confirming evidence of these compounds in the clinical COVID-19 patients [
 <xref rid="bb0745" ref-type="bibr">149</xref>].
</p>
